Navigation Links
Pharmasset Reports First Fiscal Quarter 2008 Financial Results
Date:2/14/2008

172,883 204,256

NON CURRENT PORTION OF CAPITAL LEASE

OBLIGATION - 41,641

DEFERRED REVENUE 5,261,840 5,726,131

LONG-TERM DEBT 9,520,800 -

------------------------------

Total liabilities 21,816,599 16,908,073

------------------------------

COMMITMENTS

STOCKHOLDER'S EQUITY

Common Stock, $0.001 par value,

100,000,000 shares authorized,

21,288,614 and 21,232,991 shares

issued and outstanding at

December 31, 2007 and

September 30, 2007, respectively 21,289 21,233

Warrants to purchase 66,390 shares of

common stock for $12.05 per share,

exercisable starting

September 30, 2007 526,720 526,720

Additional paid-in capital 116,633,456 115,518,201

Accumulated other comprehensive

income 4,405 4,405

Accumulated deficit (69,306,832) (57,134,233)

------------------------------

Total stockholders' equity 47,879,038 58,936,326

------------------------------

TOTAL $69,695,637 $75,844,399

==============================


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. CEL-SCI Corporation Reports First Quarter Financial Results
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
11. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...Abstinence is still the best policy , , RO...A new study from Mayo Clinic finds the use of the ...coholic hepatitis, an acute inflammation of the li...e results of the study are published in the Decemb...journal.org/ ). , , VIDEO ALERT: Additiona...
(Date:12/1/2008)...EGO, Dec. 1 Vical Incorp...pt of a $1.0 million milestone payment from Merck ...n of a Phase I clinical trial of an investigationa... vaccine is based on Vical,s DNA gene delivery tec...criptase (hTERT). hTERT is the subject of separate...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
(Date:11/25/2008)...ILLE, Ky., Nov. 25 Klei...eons performed the fifth U.S. hand transplant on M... Louisville,s Jewish Hospital Hand Care Center on ...an around noon and was completed shortly after 9 p...ttp://www.newscom.com/cgi-bin/prnh/20081125/DC4855...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Savannah Capital Management Announces 3rd Quarter Report on AMDL 28AMEX 3A ADL 29 2020 1New system for classifying infant lung disease developed 7270 1New system for classifying infant lung disease developed 7270 2New system for classifying infant lung disease developed 7270 3The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 1The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 2The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 3The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 4Categories Selected for the 2009 2825th 29 Japan Prize 7265 1Categories Selected for the 2009 2825th 29 Japan Prize 7265 2Categories Selected for the 2009 2825th 29 Japan Prize 7265 3
...weden, March, 9, 2007-Active Biotech (ACTI.ST), to...Phase Ib study of,TASQ, for the treatment of prost... dose of 1 mg/day of TASQ,was achieved, which corr...aximum tolerated dose (MTD) level of 0.5 mg/day. T...lation enables a dose,of 1 mg/day to be administer...
...(BUSINESS WIRE)--Mar 12, 2007 - Ceragenix Pharmace...mpany focused on,infectious disease and dermatolog...Ceragenin compound demonstrated virtually no biofi...yurethane catheters treated with Ceragenins,were s... with an,untreated catheter. At day 21, the cathet...
Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
(Date:12/1/2008)...1 It is a cold December day in,Me..., FedExCup Runner-up,Camilo Villegas and LPGA sta...,play golf. The impetus that has brought three of...s is something much more important than any game o...to: http://www.newscom.com/cgi-bin/prnh/20081201...
(Date:12/1/2008)... colleagues, at Memorial Sloan-Kettering Cancer Ce...odulate the expression of genes for therapeutic pu...cer therapy in mice. , Small, noncoding RNA mole...ors of gene expression. In the study, the miRNA mi...nes in immune cells known as T cells at different ...
(Date:12/1/2008)... Two Tampa Beneficiaries for Par and Poker Celebri...ec. 1 The Joyner-Walker... Bay, Inc. and the Judeo Christian Health Clinic, ...nd Poker Celebrity Challenge for Charity following... is only appropriate that events like this give ba...
(Date:12/1/2008)...with the agency,s goals, commitment and resources ... Responding to criticism that it has done a poor j... Food and Drug Administration released a report Mo..., Among the most important changes in 2008 was t...ps with state and local health departments to prot...
Breaking Medicine News(10 mins):Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4
...h: Premature babies should be brought into close p...ible after birth//, according to Germany's Profess..."There is evidence that premature babies have a be...and suffer less brain damage if they receive plent...
...e who smoke are increasingly at the risk of becomi...hat infection turn into active TB disease//, accor...ue of Archives of Internal Medicine. About one-thi...ed with the bacteria that cause tuberculosis (TB),...
...have stuffed the pungent bulbs down their throats ...rt diseases-don’t do so anymore//, say researchers...of Medicine have come out with a myth basher-garli...reducing cholesterol levels. Expressing surprise ...
...stics that frighten were presented at the Conferen... Los Angeles//, the largest scientific gathering f... made the present scenario of XDR-TB or extensivel...hat is ravaging South Africa known here. The meet...
Other Medicine News:Health News:Susceptibility to TB is High Among the Smokers 2Health News:Garlic-Not So Good Anymore 2Health News:XDR-TB: the Latest Global Terror 2
...launch of the NCP-2, ACS proudly introduces full d... more tools for assessing the administration of EC...Treatment Report.,The ACS Treatment Report is...at allows both physicians and therapists to review...
...utionary Powerheart AED G3-Automatic simplifies th...a shock button. All that you have to do is attach ... defibrillation pads are attached to the patient, ...zes the rhythm using the patented RHYTHMx software...
...ann Electronic Stethoscope Model 4100WS features a...on (ANR) technology allowing you to reduce ambient...ating critical body sounds. Three frequency modes ...her body sounds: Bell (20-200 Hz), Diaphragm (100-...
...Logic Bone Growth Stimulator is a portable, batter...tive treatment for spinal fusion. The device is wo...etic field treatment to the fusion site. The devic...d, to produce a very low energy signal that is ver...
Medicine Products: